A comprehensive NAD+ Certificate of Analysis (COA) provides quantitative verification of chemical identity, purity, and safety metrics for laboratory-grade nicotinamide adenine dinucleotide. PX1 Research delivers lot-specific COAs backed by independent ISO 17025 accredited testing facilities to ensure uncompromising reproducibility across preclinical and in vitro research applications.
A comprehensive NAD+ Certificate of Analysis (COA) provides quantitative verification of chemical identity, purity, and safety metrics for laboratory-grade nicotinamide adenine dinucleotide. PX1 Research delivers lot-specific COAs backed by independent ISO 17025 accredited testing facilities to ensure uncompromising reproducibility across preclinical and in vitro research applications.
An NAD+ Certificate of Analysis (COA) is an official analytical document verifying the batch-specific identity, purity profile, heavy metal presence, and endotoxin levels of nicotinamide adenine dinucleotide. Generated via reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry (MS), a valid COA ensures laboratory researchers receive high-purity, unadulterated research compounds for experimental reliability.
When procuring reagents for sensitive biochemical assays, relying on manufacturer claims without a verifiable COA introduces significant experimental variance. A compliant COA serves as the primary line of defense against degraded coenzymes, residual solvent contamination, and misleading purity percentages. At PX1 Research, every batch of our NAD+ research compound undergoes third-party analytical validation, ensuring that researchers receive fully documented, high-purity material matching strict structural and chemical specifications.
Nicotinamide adenine dinucleotide ($ \text{NAD}^+$) is a foundational dinucleotide coenzyme comprised of two phosphate groups joined by an anhydride bond, linking an adenine nucleoside to a nicotinamide riboside moiety. In cellular biochemistry, $\text{NAD}^+$ acts as an essential electron acceptor in metabolic redox transformations, toggling between its oxidized ($\text{NAD}^+$) and reduced ($\text{NADH}$) states during glycolysis, $\beta$-oxidation, and the citric acid cycle.
Beyond its classic metabolic role as a hydride transfer coenzyme, $\text{NAD}^+$ serves as a critical substrate for class III histone deacetylases (sirtuins, SIRT1–7), poly(ADP-ribose) polymerases (PARPs), and cyclic ADP-ribose synthases (CD38/CD157). Preclinical studies suggest that fluctuating availability of research-grade $\text{NAD}^+$ alters enzymatic kinetics in cell-free assays and cultured primary cell lines. Consequently, researchers evaluating metabolic signaling, genomic integrity maintenance, or mitochondrial bioenergetics require pristine compounds devoid of degradation products like free nicotinamide or ADP-ribose, which can act as endogenous inhibitors in non-human experimental models.
Not all analytical reports offer equal scientific rigor. In-house certificates generated without independent oversight carry an inherent risk of batch blending, peak manipulation, or obsolete data recycling. To establish absolute data integrity, PX1 Research routes every production lot to independent, ISO 17025 accredited analytical testing laboratories located within the United States.
ISO 17025 accreditation mandates strict operational standards, calibrated instrumentation, validated testing methodologies, and routine blind audits. When examining a COA from our catalog of research peptides and coenzymes, investigators can cross-reference the unique lot number displayed on the vial directly with the analytical report. This transparent chain of custody prevents quality drift, guaranteeing that empirical observations in your laboratory stem from the experimental variables tested rather than reagent impurities. Academic and commercial institutions establishing high-throughput protocols can also secure institutional procurement arrangements via our bulk lab supply accounts.
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is the gold standard method for quantifying chemical purity. During RP-HPLC analysis, the sample is dissolved in a mobile phase and pumped under high pressure through a stationary phase column packed with hydrophobic particles (typically C18). Compounds separate based on their hydrophobic interactions, eluting at specific retention times detected via UV spectrophotometry (commonly at 260 nm for dinucleotides).
The resulting HPLC chromatogram displays a series of peaks where the primary peak corresponds to pure $\text{NAD}^+$, and secondary peaks represent trace impurities or breakdown products. Purity is determined by integrating the area under the main peak relative to the total area of all detected peaks. A research-grade standard requires an RP-HPLC purity threshold of $\ge 98.0\%$. If a vendor presents a chromatogram with baseline noise, broad peak tailing, or unintegrated side peaks, the sample may contain hydrolyzed fragments that obscure assay kinetics. Understanding these analytical nuances is critical when evaluating RP-HPLC purity testing methods across suppliers.
While RP-HPLC establishes how much of the target molecule is present relative to impurities, it cannot definitively prove chemical identity on its own. Mass Spectrometry—specifically Electrospray Ionization Mass Spectrometry (ESI-MS)—is deployed to confirm the exact molecular weight and structural identity of the synthesized compound.
The theoretical monoisotopic mass of $\text{NAD}^+$ ($ \text{C}_{21}\text{H}_{27}\text{N}_{7}\text{O}_{14}\text{P}_{2}$) is approximately 663.43 g/mol. In positive ionization mode ESI-MS, the primary observed peak typically appears at $m/z \approx 664.43\ [M+H]^+$, alongside characteristic adduct peaks such as $[M+Na]^+$. The mass spectrum included within a complete PX1 Research COA demonstrates a single dominant mass signature matching the precise molecular formula, ruling out constitutional isomers, incorrect salt forms, or heavy synthesis contaminants.
Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer cell wall of Gram-negative bacteria—are potent pyrogens that interfere severely with biological assays. In cell culture models, even minute concentrations of endotoxin induce inflammatory cytokine signaling, alter receptor expression, and skew cell viability assays, generating false-positive or false-negative results.
PX1 Research subjects every batch of $\text{NAD}^+$ to rigorous Limulus Amebocyte Lysate (LAL) chromogenic kinetic testing. The lot-specific COA reports the precise endotoxin content, expressed in Endotoxin Units per milligram (EU/mg). By enforcing strict endotoxin thresholds (typically $< 0.01\ \text{EU/mg}$), we ensure that researchers studying cellular respiration, macrophage polarization, or enzymatic catalysis observe authentic biological responses unconfounded by microbial contaminants.
Synthesizing and purifying nucleotide coenzymes involves organic solvents, buffer salts, and precipitation steps. A comprehensive COA must confirm the removal of toxic residual solvents and heavy metal catalysts to prevent unwanted cytotoxicity in vitro.
Our third-party analytical protocol incorporates Gas Chromatography-Headspace (GC-HS) analysis to quantify residual organic solvents (such as methanol, ethanol, or acetonitrile) against strict USP <467> standards. Furthermore, Inductively Coupled Plasma Mass Spectrometry (ICP-MS) screens for heavy metal contaminants including lead, cadmium, arsenic, and mercury. Finally, because lyophilized $\text{NAD}^+$ is hygroscopic, Karl Fischer titration or Loss on Drying (LOD) analysis is conducted to determine moisture content, ensuring that the mass measured on your analytical balance reflects pure active compound rather than bound atmospheric water.
In experimental biology, investigators often compare $\text{NAD}^+$ directly against its intermediate precursors and reduced forms to map salvage pathways and rate-limiting steps. Understanding how structural differences impact purity testing and handling is key when designing comparative study arms.
For example, Nicotinamide Mononucleotide (NMN) represents the immediate precursor single nucleotide containing the nicotinamide group, exhibiting a smaller molecular weight (334.22 g/mol) and distinct HPLC retention parameters compared to full-length $\text{NAD}^+$. Similarly, Nicotinamide Riboside (NR) lacks both phosphate groups, altering its solubility and cellular uptake mechanisms in model systems. When evaluating reduced coenzymes such as reduced NADH, researchers must monitor UV absorbance at both 260 nm and 340 nm to track oxidation state purity—a parameter unique from oxidized $\text{NAD}^+$. A side-by-side comparison of analytical metrics for these related compounds highlights why distinct COAs are required for each variant:
To preserve the high purity certified on the COA, researchers must observe strict reconstitutive and storage procedures. Lyophilized $\text{NAD}^+$ powder is sensitive to moisture, temperature fluctuations, and pH extremes.
For optimal stability, store the dry lyophilized powder at $-20^\circ\text{C}$ or $-80^\circ\text{C}$ in a desiccated environment. When reconstituting for in vitro work, allow the vial to equilibrate to room temperature before opening to prevent condensation. Reconstitute using sterile, nuclease-free water or appropriate buffered saline (e.g., PBS at pH 7.2–7.4). Aqueous solutions of $\text{NAD}^+$ undergo slow spontaneous hydrolysis into nicotinamide and ADP-ribose over time, particularly at elevated temperatures or non-neutral pH. Aliquot reconstituted solutions immediately into single-use experimental volumes to avoid repeated freeze-thaw cycles, and store at $-80^\circ\text{C}$ until use. For detailed guidance on coenzyme handling, consult our comprehensive preclinical research hub.
The integrity of a laboratory coenzyme depends heavily on the supply chain protocols enforced long before the compound arrives at your facility. PX1 Research adheres to stringent quality control frameworks across manufacturing, testing, packaging, and fulfillment operations.
All PX1 Research compounds are manufactured in GMP-compliant facilities within the USA. Each lot undergoes immediate post-synthesis quarantine until third-party HPLC, MS, and LAL testing reports are verified. Orders are fulfilled directly from our temperature-controlled dispatch centers in California and Arizona, featuring same-day shipping for orders placed Monday through Friday before cut-off times. This rapid, domestic logistics chain minimizes transit degradation and guarantees that the physical compound delivered to your bench matches the exact specifications detailed on its accompanying Certificate of Analysis.
What exact parameters are verified on an NAD+ Certificate of Analysis?
A complete NAD+ COA verifies chemical identity via Mass Spectrometry (ESI-MS), purity percentage via Reverse-Phase HPLC, endotoxin concentration via chromogenic LAL testing, heavy metal content via ICP-MS, residual solvent levels via GC-HS, and physical appearance/solubility profiles.
How do I match my vial of NAD+ to its specific COA?
Every PX1 Research product label features a distinct, lot-specific batch number. This batch number directly corresponds to the lot number published on the independent third-party COA, ensuring full traceability from synthesis to laboratory delivery.
Why is third-party ISO 17025 testing superior to manufacturer testing?
Third-party ISO 17025 accredited laboratories operate independently of product sales, utilizing validated analytical methods and calibrated equipment subject to regular impartial audits. This eliminates potential conflicts of interest and prevents peak integration tampering or data recycling.
What is the acceptable RP-HPLC purity threshold for research-grade NAD+?
For reliable in vitro and preclinical research, NAD+ should demonstrate an RP-HPLC purity of $\ge 98.0\%$. Lower purity levels indicate the presence of degradation products like nicotinamide or ADP-ribose, which can act as enzymatic inhibitors in cell assays.
What is the endotoxin limit for PX1 Research NAD+ batches?
PX1 Research enforces strict endotoxin standards, verifying that batches contain $< 0.01\ \text{EU/mg}$ via LAL testing. This ensures that the compound will not trigger non-specific inflammatory responses or confound cell culture data.
Can NAD+ degrade during shipping?
Lyophilized NAD+ is chemically stable at ambient temperatures during short-term transit. To ensure maximum stability, PX1 Research ships orders same-day (Monday–Friday) from our CA and AZ facilities using rapid domestic transit. Upon receipt, store the compound at $-20^\circ\text{C}$ or $-80^\circ\text{C}$ for long-term preservation.
How should NAD+ be reconstituted for in vitro assay use?
Reconstitute lyophilized NAD+ using sterile, cold, nuclease-free water or buffered saline (pH 7.0–7.4). Avoid high heat or extreme pH levels. Prepare single-use aliquots to eliminate freeze-thaw cycles, which accelerate molecular hydrolysis.
Is PX1 Research NAD+ intended for human consumption or administration?
No. All compounds supplied by PX1 Research, including NAD+, are strictly for laboratory research, in vitro experimentation, and preclinical research use only. They are not for human or animal consumption, medical treatment, or diagnostic applications.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.